Adaptive Biotechnologies Corporation
DE ˙ MUN ˙ US00650F1093
13,58 € ↑0,76 (5,89%)
2026-06-04
DEL PRIS
SecurityDE:1HM / Adaptive Biotechnologies Corporation
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership20,900 shares
Latest Disclosed Value $ 290,032
Captrust Financial Advisors reports 3.29% increase in ownership of 1HM / Adaptive Biotechnologies Corporation

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 20,900 shares of Adaptive Biotechnologies Corporation (DE:1HM) valued at $232,826 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 20,235 shares of Adaptive Biotechnologies Corporation. This represents a change in shares of 3.29% during the quarter. The current value of the position is $283,822 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 20,900 665 3.29 290 -11.59 0.0005
2026-02-17 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 20,235 305 1.53 329 10.07 0.0006
2025-11-19 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 19,930 4,168 26.44 298 62.84 0.0006
2025-08-15 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 15,762 1,119 7.64 184 69.44 0.0004
2025-05-15 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 14,643 1,059 7.80 109 33.33 0.0003
2025-02-14 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 13,584 654 5.06 81 22.73 0.0002
2024-11-14 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 12,930 1,617 14.29 66 65.00 0.0002
2024-08-15 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 11,313 1,019 9.90 41 21.21 0.0001
2024-05-15 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 10,294 -1,700 -14.17 33 -43.10 0.0001
2024-02-14 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 11,994 539 4.71 59 -6.45 0.0002
2023-11-15 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 11,455 -740 -6.07 62 -23.46 0.0002
2023-08-15 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 12,195 69 0.57 82 -24.30 0.0003
2023-05-15 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Stock 00650F109 12,126 12,126 107 0.0005
2023-02-15 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM ADR 00650F109 0 -12,317 -100.00 0 -100.00
2022-11-16 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM ADR 00650F109 12,317 11,162 966.41 88 877.78 0.0005
2022-08-23 2022-06-30 13F/A-1 ADAPTIVE BIOTECHNOLOGIES CORP COM Common Stock 00650F109 1,155 -373 -24.41 9 -57.14 0.0001
2022-08-16 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM COM 00650F109 1,312 -216 11 0.0001
2022-05-16 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,528 758 98.44 21 -4.55 0.0001
2022-02-14 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Common Stock 00650F109 770 180 30.51 22 10.00 0.0002
2021-11-16 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Common Stock 00650F109 590 0 0.00 20 -16.67 0.0002
2021-08-16 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Common Stock 00650F109 590 -870 -59.59 24 -59.32 0.0002
2021-05-17 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Common Stock 00650F109 1,460 270 22.69 59 -15.71 0.0006
2021-02-16 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Common Stock 00650F109 1,190 -6 -0.50 70 18.64 0.0009
2020-11-17 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES CORP COM Common Stock 00650F109 1,196 1,196 59 0.0010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.